New cause of Tamoxifen resistance is found

Aug 13, 2007

U.S. scientists have discovered a new mechanism for resistance to Tamoxifen and Faslodex endocrine or anti-hormonal breast cancer therapies.

The researchers at the Lombardi Comprehensive Cancer Center at the Georgetown University Medical Center said their findings might allow oncologists to screen women for responsiveness to such treatments, and provide clues to reversing resistance.

The research, led by Professor Robert Clarke, indicates a gene -- X-box binding protein-1, or XBP1 -- previously thought to be unrelated to breast cancer might be responsible for some resistance to endocrine therapy.

The researchers said the gene is an alternatively spliced transcription factor that participates in a stress-signaling pathway to protect cells from damage. Clarke and his colleagues determined over-expression of the spliced variant of the gene in estrogen receptor-positive breast cancer cells led to reduced sensitivity to Tamoxifen and Faslodex.

The study was published online in the July 27 issue of the Journal of the Federation of American Societies for Experimental Biology.

Copyright 2007 by United Press International

Explore further: Chronic inflammation linked to 'high-grade' prostate cancer

add to favorites email to friend print save as pdf

Related Stories

Clue to unusual drug-resistant breast cancers found

Oct 08, 2010

Researchers at the University of Illinois at Chicago College of Medicine have found how gene expression that may contribute to drug resistance is ramped up in unusual types of breast tumors. Their findings may offer new therapy ...

Study: 2 good choices to prevent breast cancer

Apr 19, 2010

(AP) -- Older women at higher risk for breast cancer now have two good drug options for preventing the disease, but they will have to weigh the trade-offs, a major study shows.

How breast cancer cells evade therapeutic attacks

Mar 31, 2010

Tumour cells depend upon estrogens to survive and proliferate in about 70% of all breast cancer cases. The most frequently used treatment to fight this variety of tumours relies on anti-estrogens such as tamoxifen. However, ...

Hormone-blocking drug reduces breast cancer risk

Jun 04, 2011

(AP) -- Millions of women at higher-than-usual risk of breast cancer have a new option for preventing the disease. Pfizer Inc.'s Aromasin cut the risk of developing breast cancer by more than half, without the side effects ...

Recommended for you

Unraveling the 'black ribbon' around lung cancer

Apr 17, 2014

It's not uncommon these days to find a colored ribbon representing a disease. A pink ribbon is well known to signify breast cancer. But what color ribbon does one think of with lung cancer?

User comments : 0

More news stories

Impact glass stores biodata for millions of years

(Phys.org) —Bits of plant life encapsulated in molten glass by asteroid and comet impacts millions of years ago give geologists information about climate and life forms on the ancient Earth. Scientists ...